SELDI protein profiling of dunning R-3327 derived cell lines: Identification of molecular markers of prostate cancer progression

BACKGROUND We recently demonstrated the protein expression profiling of Dunning rat tumor cell lines of varying metastatic potential (G (0%), AT‐1 (∼20%), and MLL (100%)) using SELDI‐TOF‐MS. As a parallel effort, we have been pursuing the identification of the protein(s) comprising the individual discriminatory “peaks” and evaluating their utility as potential biomarkers for prostate cancer progression. METHODS To identify the observed SELDI‐TOF‐MS m/z (mass/charge) values with discriminatory expression between different sublines, we employed a combination of chemical pre‐fractionation, liquid chromatography, gel electrophoresis and tandem mass spectroscopy. Identified proteins were then verified by immuno‐assay and Western analysis. RESULTS A 17.5 K m/z SELDI‐TOF‐MS peak was found to retain discriminatory value in each of two separate study‐sets with an increased expression in the metastatic MLL line. Sequence identification and subsequent immunoassays verified that Histone H2B is the observed 17.5 K m/z SELDI peak. SELDI‐based immuno‐assay and Western Blotting revealed that Histone H2B is specifically over‐expressed in metastatic MLL lines. CONCLUSIONS SELDI‐TOF MS analysis of the Dunning prostate cancer cell lines confirmed the consistent overexpression of a 17.5 K m/z peak in metastatic MLL subline. The 17.5 kDa protein from MLL has been isolated and identified as Histone H2B. Prostate 67: 1565–1575, 2007. © 2007 Wiley‐Liss, Inc.